Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial

2009 ◽  
Vol 13 (2) ◽  
pp. 183-190 ◽  
Author(s):  
S. Yancheva ◽  
R. Ihl ◽  
G. Nikolova ◽  
P. Panayotov ◽  
S. Schlaefke ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Ginkgo Biloba ◽  
Ginkgo Biloba Extract ◽  
Egb 761 ◽  
Double Blind ◽  
Exploratory Trial

Effects of the standardized Ginkgo biloba extract EGb 761® on neuroplasticity

2012 ◽  
Vol 24 (S1) ◽  
pp. S21-S24 ◽  
Author(s):  
Walter E. Müller ◽  
Jeanine Heiser ◽  
Kristina Leuner
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Ginkgo Biloba ◽  
Long Term Potentiation ◽  
Ginkgo Biloba Extract ◽  
Egb 761 ◽  
Spine Density ◽  
Term Potentiation ◽  
Structural Adaptations

ABSTRACTNeuroplasticity, the ability of synapses to undergo structural adaptations in response to functional demand or dysfunctions is increasingly impaired in aging and Alzheimer's disease. EGb761® has been shown in several preclinical reports to increase nearly all aspects of impaired neuroplasticity (long-term potentiation, spine density, neuritogenesis, neurogenesis). While all three fractions of constituents (ginkgolides, flavonoids, bilobalide) seem to be active, the flavonoids and specifically the aglycone isorhamnetin seem to be most relevant.

Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer’s Disease: A Network Meta-Analysis

Drugs & Aging ◽  
2019 ◽  
Vol 36 (5) ◽  
pp. 435-452 ◽  
Author(s):  
Onnita Thancharoen ◽  
Chulaporn Limwattananon ◽  
Onanong Waleekhachonloet ◽  
Thananan Rattanachotphanit ◽  
Phumtham Limwattananon ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Ginkgo Biloba ◽  
Cholinesterase Inhibitors ◽  
Meta Analysis ◽  
Ginkgo Biloba Extract
Sign in / Sign up

Export Citation Format

Share Document